Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia

被引：5
|
作者：
Fiorini, A. [1 ]
Reddiconto, G. [1 ]
Farina, G. [1 ]
Marietti, S. [1 ]
Palladino, M. [1 ]
Chiusolo, P. [1 ]
Leone, G. [1 ]
Sica, S. [1 ]
机构：
[1] Catholic Univ Rome, Inst Hematol, Rome, Italy
来源：
LEUKEMIA | 2006年 / 20卷 / 12期
关键词：
D O I：
10.1038/sj.leu.2404430
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2198 / 2199
页数：2
相关论文
共 50 条
  • [1] Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia
    Fiorini, A.
    Reddiconto, G.
    Farina, G.
    Marietti, S.
    Palladino, M.
    Giammarco, S.
    Chiusolo, P.
    Leone, G.
    Sica, S.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S298 - S298
  • [2] Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia
    A Fiorini
    G Reddiconto
    G Farina
    S Marietti
    M Palladino
    P Chiusolo
    G Leone
    S Sica
    Leukemia, 2006, 20 : 2198 - 2199
  • [3] Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia
    Ruiz-Arguelles, Guillermo J.
    Garces-Eisele, Javier
    Reyes-Nunez, Virginia
    Ruiz-Delgado, Guillermo J.
    Rosillo, Carlos
    Camoriano, John K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (05) : 400 - 402
  • [4] Incidence and clinical profile of JAK2 V617F mutation in myelofibrosis with myeloid metaplasia.
    Barosi, G
    Marchetti, M
    Massa, M
    Rosti, V
    Vannucchi, A
    Invernizzi, R
    Campanelli, R
    Viarengo, G
    Magrini, U
    Bergamaschi, G
    BLOOD, 2005, 106 (11) : 78A - 78A
  • [5] No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis
    Ditschkowski, Markus
    Elmaagacli, Ahmet H.
    Trenschel, Rudolf
    Steckel, Nina K.
    Koldehoff, Michael
    Beelen, Dietrich W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (12) : 1350 - 1351
  • [6] V617F mutation in JAK2 is associated idiopathic myelofibrosis
    Campbell, PJ
    Griesshammer, M
    Döhner, K
    Döhner, H
    Kusec, R
    Hasselbalch, HC
    Larsen, TS
    Pallisgaard, N
    Giraudier, S
    Le Bousse-Kerdilès, MC
    Desterke, C
    Guerton, B
    Dupriez, B
    Bordessoule, D
    Fenaux, P
    Kiladjian, JJ
    Viallard, JF
    Brière, J
    Harrison, CN
    Green, AR
    Reilly, JT
    BLOOD, 2006, 107 (05) : 2098 - 2100
  • [7] Decreased JAK2 V617F allele burden level in a myelofibrosis with myeloid metaplasia patient with leukemic transformation
    Wu, Yi-Ying
    Hung, Hsiu-Man
    Chen, Tien-Sheng
    Chao, Tsu-Yi
    Ho, Ching-Liang
    LEUKEMIA RESEARCH, 2008, 32 (11) : 1783 - 1786
  • [8] Prognostic relevance of JAK2 V617F mutation in primary myelofibrosis
    Barosi, G.
    Bergamaschi, G.
    Marchetti, M.
    Massa, M.
    Rosti, V.
    Bonetti, E.
    Vannucchi, A. M.
    Guglielmelli, P.
    Antonioli, E.
    Campanelli, R.
    Villani, L.
    Viarengo, G. L.
    Barbui, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 241 - 241
  • [9] Neutrophilia and the JAK2 V617F Mutation
    Langabeer, Stephen E.
    Haslam, Karl
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 437 - 438
  • [10] DOES ALLELE BURDEN IMPORT IN MYELOFIBROSIS WITH JAK2 V617F MUTATION?
    Maria Isabel, Montero Cuadrado
    Francisco Jose, Marquez Malaver
    Cruz Estrella, Carrillo
    Canale Silvia, Garcia
    Lucia, Mezquita
    Javier, Delgado
    Caro Rocio, Marin
    Francisco Jose, Martin Dominguez
    Nancy, Rodriguez
    Campos Jose, Gonzalez
    Jose Francisco, Falantes
    Jose Antonio, Perez Simon
    HAEMATOLOGICA, 2021, 106 (10) : 258 - 258
12345